ePlus
PLUS
92.79
-1.37
-1.46%
ePlus
US · PLUS
#2648 by market cap
Listed 1970
92.79
-1.37
-1.46%
Live - 5344 symbols - heartbeat 94s ago
· 2026-10-07 19:54
After-hours
92.79
0.00%
- Market cap
- 2.42B
- P/E (TTM)i
- 20.26
- P/Bi
- 2.26
- EPSi
- 5.03
- Div yieldi
- 1.10%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on PLUS?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Scotiabank Maintains 5N PLUS INC(FPLSF.US) With Buy Rating, Raises Target Price to $26.1Market Newswire · 2026/9/28
-
Rating change
Lenovo Group (00992.HK): The cloud-plus-edge AI server upcycle continues, and ISG's profitability is expected to improve significantly.Kaiyuan Securities · 2026/8/28
-
Reported Sunday, Suncor To Sell Non-Core Offshore Assets For C$1.2B Cash Plus Up To C$350M Contingent, Lifts Monthly Buybacks To C$750M From C$500MBenzinga · 2026/10/5
-
Rating change
Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Maintains Target Price $86Market Newswire · 2026/9/15
-
Nvidia Is Approaching a Breakout Level. Plus, What We Want to See From MicronCNBC · 2026/9/30
-
Rating change
Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Announces Target Price $86Market Newswire · 2026/9/10
-
William Blair Maintains EPlus(PLUS.US) With Buy RatingMarket Newswire · 2026/9/30
-
Company notice
A.PLUS GROUP: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026HKEX · 2026/10/2
-
Wall Street Is Closing Out a Strong Quarter. Plus, Lilly's Mixed Obesity Drug Trial DataCNBC · 2026/10/1
-
Rating change
Ying'en Bio-B (09606.HK): Core product registrations and clinical progress are being steadily realized; the ADC plus second-generation IO combination therapy is highly anticipated.Essence Securities · 2026/9/2
-
Company notice
Plus Alpha Consulting: "AI Plus Talk" has shortened Yamato Contact Service's new‑employee training from two weeks to three days—leveraging AI‑powered role‑plays to accelerate workforce readiness and enhance service quality.JPX · 2026/10/6
-
Company notice
AltPlus Holdings: Statutory Post-Disclosure Documents (Absorption-Type Corporate Split) (Ortho Plus Co., Ltd.)JPX · 2026/10/1
-
Rating change
Sungrow (300274): A leading player in solar-plus-storage is accelerating its AIDC deployment, with a steady stream of new products for large-scale energy storage, commercial applications, and industrial use.Western Securities · 2026/8/30
-
Rating change
CanFang Bio (9926.HK): In a head-to-head Phase III trial in first-line biliary tract cancer, AK112 demonstrated significantly superior overall survival compared to durvalumab plus chemotherapy, further validating its potential.China Securities Co., Ltd. · 2026/8/27
-
Rating change
Deutsche Bank Initiates CANAL PLUS SA(CNALF.US) With Buy Rating, Announces Target Price $4.47Market Newswire · 2026/9/9
-
Rating change
5N Plus Inc. Is Maintained at Sector Outperform by Scotia CapitalDow Jones · 2026/9/28
-
Rating change
5N Plus Inc. Price Target Raised to C$37.00/Share From C$35.00 by Scotia CapitalDow Jones · 2026/9/28
-
Company notice
S-Pool: The Japan Association of Employers Promoting Employment of Persons with Disabilities, to which Espool Plus is a member, has established business guidelines for employment support services for persons with disabilities.JPX · 2026/10/1
-
Company notice
GMO Payment Gateway: GMO Reserve Plus has launched a new option for first- and second-tier veterinary hospitals, digitizing referral scheduling and information sharing among animal clinics through "Animary by GMO."JPX · 2026/10/1
-
Genentech's Giredestrant Plus Everolimus Cuts Risk Of Progression Or Death 44% In ITT And 62% In ESR1-Mutated ER-Positive Advanced Breast Cancer In Phase III EvERA; FDA Goal Dates Are Dec. 18 For Advanced Disease And Nov. 30 For Early-Stage DiseaseBenzinga · 2026/10/1
-
Nvidia Breaks Through to New Record Highs. Plus, More Good News for BoeingCNBC · 2026/10/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.